Abstract
CYSTIC fibrosis is associated with a defect in epithelial chloride ion transport (reviewed in refs 1, 2) which is caused by mutations in a membrane protein called CFTR (cystic fibrosis transmembrane conductance regulator)3. Heterologous expression of CFTR produces cyclicAMP-sensitive Cl--channel activity4–7.Deletion of phenylalanine at amino-acid position 508 in CFTR (ΔF508 CFTR) is the most common mutation in cystic fibrosis8. It has been proposed that this mutation prevents glycoprotein maturation and its transport to its normal cellular location9. We have expressed both CFTR and ΔF508 CFTR in Vero cells using recombinant vaccinia virus. Although far less ΔF508 CFTR reached the plasma membrane than normal CFTR, sufficient ΔF508 CFTR was expressed at the plasma membrane to permit functional analysis. ΔF508 CFTR expression induced a reduced activity of the cAMP-activated Cl- channel, with conductance, anion selectivity and open-time kinetics similar to those of CFTR, but with much greater closed times, resulting in a large decrease of open probability. The ΔF508 mutation thus seems to have two major consequences, an abnormal translocation of the CFTR protein which limits membrane insertion, and an abnormal function in mediating Cl- transport.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Quinton, P. M. FASEB J. 4, 2709–2717 (1990).
Welsh, J. M. FASEB J. 4, 2718–2725 (1990).
Riordan, J. R. et al. Science 245, 1066–1073 (1989).
Anderson, M. P., Rich, D. P., Gregory, R. J., Smith, A. E. & Welsh, M. J. Science 251, 679–682 (1991).
Rich, D. P. et al. Nature 347, 358–363 (1990).
Drumm, M. L. et al. Cell 62, 1227–1233 (1990).
Kartner, N. et al. Cell 64, 681–691 (1991).
Kerem, B. S. et al. Science 245, 1073–1080 (1989).
Cheng, S. H. et al. Cell 63, 827–834 (1990).
Moss, B. Science 252, 1662–1667 (1991).
Gregory, R. J. et al. Nature 347, 382–386 (1990).
Venglarik, C. V., Bridges, R. J. & Frizzell, R. A. Am. J. Physiol. 259, C358–364 (1990).
Cliff, W. H. & Frizzell, R. A. Proc. natn. Acad. Sci. U.S.A. 87, 4956–4960 (1990).
Dreinhöfer, J., Gögelein, H. & Greger, R. Biochim. biophys. Acta 946, 135–142 (1988).
Gray, M. A. et al. Am. J. Physiol. 259, C752–761 (1990).
Champigny, G., Verrier, B., Gérard, C., Mauchamp, J. & Lazdunski M. FEBS Lett. 259, 263–268 (1990).
Tabcharani, J. A., Low, W., Elie, D. & Hanrahan, J. W. FEBS Lett. 270, 157–174 (1991).
Lazdunski, M. & Renaud, J.-F. A. Rev. Physiol. 44, 463–473 (1982).
Triggle, D. J. & Janis, R. A. A. Rev. Pharmac. Tox. 27, 347–369 (1987).
Edwards, G. & Weston, A. Trends pharmac. Sci. 11, 417–422 (1990).
Barbry, P. et al. Proc. natn. Acad Sci. U.S.A. 87, 7347–7351 (1990).
Marchalonis, J. J. Biochem. J. 113, 673–675 (1969).
Hamill, O. P., Marty, A., Neher, E., Sakmann, B. & Sigworth, F. J. Pflügers Arch. 391, 85–100 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dalemans, W., Barbry, P., Champigny, G. et al. Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation. Nature 354, 526–528 (1991). https://doi.org/10.1038/354526a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/354526a0
- Springer Nature Limited
This article is cited by
-
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel
Scientific Reports (2023)
-
Gene–environment interactions and their impact on human health
Genes & Immunity (2022)
-
The NSAID glafenine rescues class 2 CFTR mutants via cyclooxygenase 2 inhibition of the arachidonic acid pathway
Scientific Reports (2022)
-
Pharmacological chaperone-rescued cystic fibrosis CFTR-F508del mutant overcomes PRAF2-gated access to endoplasmic reticulum exit sites
Cellular and Molecular Life Sciences (2022)
-
Esc peptides as novel potentiators of defective cystic fibrosis transmembrane conductance regulator: an unprecedented property of antimicrobial peptides
Cellular and Molecular Life Sciences (2022)